Phase3Trial

AstraZeneca's Ultomiris Poised for Accelerated Approval in IgA Nephropathy After Striking Trial Results

A Beacon of Hope: Personalized mRNA Vaccine Targets Pancreatic Cancer Recurrence

A Beacon of Hope: Personalized mRNA Cancer Vaccine Shows Promise Against Pancreatic Cancer

A New Frontier in Cancer Treatment: The Promise of mRNA Vaccines

Eli Lilly's Retatrutide Triumphs in Key Diabetes Trial, Poised to Reshape Obesity Treatment Landscape

Inovio's INO-3107: A High-Stakes Bet on a Potential RRP Game-Changer

InflaRx's Vilobelimab: A Deeper Look into Pyoderma Gangrenosum Trial Data

A Glimmer of Hope for Hair Loss Sufferers: Cosmo Pharma's Breezula Delivers in Landmark Trial

A Glimmer of Hope? Novo Nordisk's GLP-1 Drug and the Alzheimer's Enigma

A Bittersweet Wait: Immuron's Travelan Data Faces an Unexpected Delay

The Shaking Ground: Intellia's Gene-Editing Dream Hits a Harsh Reality Check with Trial Setback

Breakthrough in Lung Cancer Treatment: Positive Phase 3 OPTITROP-Lung04 Trial Results for Sacituzumab Tirumotecan Unveiled

MoonLake Immunotherapeutics Skyrockets: Is a Biotech Buyout Imminent After Breakthrough Skin Drug Trial?

Palvella Therapeutics' QTORIN: A Glimmer of Hope Nears for Pachyonychia Congenita Sufferers

Game Changer in Obesity Treatment: Novo Nordisk's Oral Wegovy Pill Achieves Remarkable 16.6% Weight Loss in Phase 3 Trial

BioNTech Soars: Landmark Phase 3 Success for Breast Cancer Therapy

Glenmark Soars as Pioneering Cancer Drug Envafolimab Enters Crucial Multi-Nation Phase 3 Trial